The obesity epidemic has forced us to evaluate the role of inflammation in the health
complications of obesity. This has led to a convergence of the fields of immunology and …

Recent studies have linked human gut microbes to obesity and inflammatory bowel disease,
but consistent signals have been difficult to identify. Here we test for indicator taxa and …

METHODS: We created an EHR-based cohort of adult patients with IBD who were new
users of biologic agents (tumor necrosis factor [TNF-α] antagonists, ustekinumab, and …

Background and aims: Obesity is unusual in Crohn's disease and the particularities of the
disease in obese patients have not been studied. Methods: 2065 patients were studied …

Obesity has consistently been associated with an increased risk of metabolic abnormalities
such as diabetes, hyperlipidemia, and cardiovascular diseases, as well as the development …

Inflammatory bowel disease (IBD) is a chronic inflammatory condition of the gastrointestinal
tract, thought to at least in part reflect an aberrant immune response to gut bacteria. IBD is …

Crohn's disease and ulcerative colitis, collectively known as IBD, are chronic inflammatory
disorders of the gastrointestinal tract. Although the aetiopathogenesis of IBD is largely …

Irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) are two of the leading
causes of chronic intestinal conditions in the world. This issue of World Journal of …

Abstract Background and Aims Alterations in body composition are common in inflammatory
bowel disease [IBD] and have been associated with differences in patient outcomes. We …

Background Obesity is associated with systemic and intestine-specific inflammation and
alterations in gut microbiota, which in turn impact mucosal immunity. Nonetheless, a specific …